Latest financial market updates and expert analysis
Analysis There’s a moment every small-cap biotech dreads: the day regulatory approval arrives, and the market yawns. Outlook Therapeutics is living that moment right now. The company secured FDA clearance for...
There is a peculiar tension at the heart of Xiaomi’s current market narrative. Between early June and mid-July, the company...
The hydrogen sector has never been short on ambition, and Ballard Power’s proposed acquisition of GeoPura is a case in...
Copper prices are touching unprecedented territory on the Comex, with the red metal trading above $14,800 per tonne. Yet for...
The stock market has a habit of rewarding companies that sit at the intersection of geopolitics and industrial policy, and...
There is a peculiar disconnect unfolding at PNE. The wind and solar project developer just delivered the kind of half-year...
The pressure building on Volkswagen’s management has reached a critical juncture. The controlling Porsche and Piëch families, according to Reuters,...
The engine maker’s half-year scorecard has handed investors plenty to cheer about, yet the real test arrives on 24 August...
The market has already made up its mind about Nokia’s artificial intelligence ambitions — the question now is whether the...
Deutsche Telekom is running a multi-track playbook right now — returning cash to shareholders through steady buybacks, pushing fibre deeper...
There is a peculiar arithmetic at work in Copenhagen these days: a company raises its full-year outlook, beats on revenue,...
